Thousands of medical marijuana patients in the United States rely on the drug to alleviate a multitude of symptoms from cachexia to nerve pain; nevertheless, the Drug Enforcement Administration (DEA) still considers it a Schedule I controlled substance that has no accepted medical use. Despite this law-enforcement-agency-approved “analysis,” doctors are conducting their own research. In Israel, the Meir Medical Center is recruiting Crohn's Disease sufferers for a study on the ability of marijuana…